
Trxade Group MEDS
Quarterly report 2026-Q1
added 05-15-2026
Trxade Group EV/EBITDA Ratio 2011-2026 | MEDS
Annual EV/EBITDA Ratio Trxade Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.176 | -1.73 | -3.87 | -0.872 | -2.87 | -21.6 | -96 | 45.8 | 5.9 | -0.95 | -41.6 | -5.43 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 45.8 | -96 | -10.3 |
EV/EBITDA Ratio of other stocks in the Pharmaceutical retailers industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Аптеки 36.6
APTK
|
17.3 | - | - | - | ||
|
BOQI International Medical
BIMI
|
-4.96 | - | 6.33 % | $ 5.86 M | ||
|
Greenlane Holdings
GNLN
|
0.419 | $ 3.06 | -5.99 % | $ 22.9 M | ||
|
China Jo-Jo Drugstores, Inc.
CJJD
|
-13.4 | - | -5.59 % | $ 49.9 M | ||
|
PetMed Express
PETS
|
10.7 | $ 2.12 | -2.3 % | $ 43.7 M | ||
|
Rite Aid Corporation
RAD
|
29.2 | - | - | $ 35.5 M | ||
|
Walgreens Boots Alliance
WBA
|
-6.59 | - | - | $ 10.3 B | ||
|
111
YI
|
-0.539 | $ 5.7 | 1.42 % | $ 979 M | ||
|
LifeMD
LFMD
|
-27.5 | $ 4.19 | 2.95 % | $ 189 M |